L-Carnitine is a naturally occurring amino acid that has the overall effect of burning fat, boost energy and reduce fatigue
Those making such claims demonstrate disregard for regulatory compliance
& Elmquist, J
This injectable medication, a GGG Tri-agonist or GLP-1/GIP/glucagon tri-agonist, is on the verge of gaining FDA approval
Regulatory status: Retatrutide is not approved by the FDA, EMA, or any other regulatory body, and the FDA has explicitly stated it cannot be used in compounding under federal law [5][6]
However, this possibility seems unlikely, because over comparable periods of time, treatment with GLP-1 receptor agonists (which also enhance signaling through the GLP-1 pathway) reduced the risk of atherosclerotic ischemic events [51, 52]